Quintrio
Home

CIGARETTES

Ispire Technology Inc. Common Stock

ISPR

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded and non-branded vaping hardware products in both the nicotine and cannabis spaces, as well as the assembly of nicotine pouch products and other next-generation nicotine products. The company sells its e-cigarette and pouch products globally, in markets where it is legally permitted to do so. The majority of its nicotine products are marketed under the Aspire brand name, and the cannabis products are marketed under the Ispire brand name. Geographically, the company generates the majority of its revenue from Europe, followed by North America, Asia Pacific, and other markets.

Last trade $1.52
Day change $0.00 (0.00%)
Day range $1.37 – $1.52
Volume 7,093
Market cap $88M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$87.8M
Price / earnings
—
Price / book
-2.52×
Price / sales
0.94×
EV / sales
0.78×
EV / EBITDA
-2.07×

Profitability

Earnings per share
-$0.63
Return on assets
-68.88%
Return on equity
104.41%
Dividend yield
0%

Liquidity and leverage

Debt / equity
-0.01×
Current ratio
1.01×
Quick ratio
0.94×
Cash ratio
0.46×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$1.3M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ISPR, quarterly periods
Line itemQ1 FY2027 Sep 30, 2026Q4 FY2026 Jun 30, 2026Q3 FY2026 Mar 31, 2026Q2 FY2026 Dec 31, 2025Q1 FY2026 Sep 30, 2025Q4 FY2025 Jun 30, 2025Q3 FY2025 Mar 31, 2025Q2 FY2025 Dec 31, 2024
Revenue$27.54M$26.69M$18.69M$20.29M$30.35M$20.14M$26.19M$41.83M
Cost of revenue$23.09M$25.01M$16.69M$16.81M$25.2M$17.66M$21.41M$34.11M
Gross profit$4.45M$1.69M$1.99M$3.47M$5.15M$2.48M$4.78M$7.72M
Selling, general and administrative$5.85M$6.05M$5.91M$6.14M$6.08M$8.47M$9.26M$10.9M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$10.6M$15.22M$11.47M$10.35M$7.84M$17.12M$15.36M$15.08M
Operating income-$6.15M-$13.54M-$9.48M-$6.87M-$2.7M-$14.64M-$10.59M-$7.36M
Interest expense-$62.42K-$74.59K-$87.22K-$100.19K-$112.18K-$128.58K-$35.65K-$13.07K
Income before taxes-$6.1M-$13.44M-$9.35M-$6.5M-$2.77M-$14.68M-$10.68M-$7.54M
Income taxes$336.64K$377.32K$177.41K$106.59K$486.07K$109.93K$176.99K$460.03K
Net income-$6.44M-$13.82M-$9.52M-$6.6M-$3.26M-$14.79M-$10.86M-$8M
Net income attributable to common shareholders-$6.44M-$13.82M-$9.52M-$6.6M-$3.26M-$14.79M-$10.86M-$8M
EBITDA-$5.93M-$13.29M-$9.27M-$6.65M-$2.44M-$14.42M-$10.39M-$7.17M
Basic earnings per share-$0.11-$0.24-$0.17-$0.12-$0.06-$0.26-$0.19-$0.14
Diluted earnings per share-$0.11-$0.24-$0.17-$0.12-$0.06-$0.26-$0.19-$0.14

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Universal Corp. (UVV) Q2 Earnings and Revenues Miss Estimates

Universal Corp. (UVV) reported quarterly earnings of $0.39 per share, missing consensus estimates of $0.58 and down significantly from $1.36 a year ago. The company also missed revenue expectations at $621.85 million versus $754.18 million year-over-year. With a Zacks Rank #3 (Hold) rating and stock down 25.2% year-to-date, the company faces headwinds despite the tobacco industry ranking in the top 46% of Zacks industries.

Benzinga

Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma

Ispire Technology announced a joint venture with Shandong Jincheng Pharmaceutical Group to manufacture and commercialize nicotine pouch products, marking the company's entry into the rapidly expanding oral nicotine category. The nicotine pouch market was valued at approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion. Jincheng Pharma will contribute manufacturing equipment and expertise while Ispire provides regulatory compliance and global distribution capabilities.

GlobeNewswire Inc.

Raw Garden Introduces Sprout™ Vape, Pioneering Terpene-Safe Plastic for Cannabis Hardware

Raw Garden, a leading cannabis extract company in California, has developed a terpene-safe solution for its new Sprout all-in-one cannabis vape. The company found that the commonly used PCTG plastic in vape hardware could pose health risks when exposed to their terpene-rich cannabis oils, so they worked with their manufacturing partner Ispire Technology to identify a safer alternative, PA12 plastic.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.